Researchers reviewed how ginsenosides, along with other active components in ginseng like polysaccharides and essential oils, might affect neurodegenerative diseases. These include Alzheimer's disease, Parkinson's disease, Huntington's disease, and Amyotrophic Lateral Sclerosis (ALS). The review looked at how these compounds interact with brain health and cellular functions.
The findings suggest that ginsenosides may offer neuroprotective effects. They may work by regulating protein aggregation, reducing glutamate excitotoxicity, and restoring antioxidant balance in the brain. In animal models, these components were shown to improve both behavioral and pathological indicators for several of the conditions mentioned.
It is important to note that this evidence comes primarily from preclinical studies, meaning it has not been tested in humans yet. While new delivery methods like nanoparticles could help these compounds reach the brain more effectively, clinical success is not yet established. Patients should consult a doctor before making any changes to their treatment plans.
